Table 1. Characteristics of the studies included in the meta-analysis.
| Studies | Region | LncRNAs | Tumour type | Expression | Method | Study population (high/low) |
Cut-off | Follow-up (month) |
Outcome | Quality score (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Zhang et al. [18] 2016 | China | H19 | NSCLC | up-regulation | qPCR | 35/35 | median | 60 | OS | 83.3% |
| Sun et al. [14] 2014 | China | BANCR | NSCLC | down-regulation | qPCR | 53/60 | fold change | 40 | OS/PFS | 83.3% |
| Zhang et al. [19] 2014 | China | ZXF1 | NSCLC | up-regulation | qRT-PCR | 43/19 | ratio | 36 | OS | 73.8% |
| Sun et al. [20] 2014 | China | SPRY4-IT1 | NSCLC | down-regulation | qRT-PCR | 60/61 | fold change | 40 | OS/PFS | 73.8% |
| Yang et al. [21] 2014 | China | PVT1 | NSCLC | up-regulation | qRT-PCR | 65/17 | median | 60 | OS | 83.3% |
| Wan et al. [22] 2016 | China | PCAT6 | NSCLC | up-regulation | qRT-PCR | 28/26 | mean | 60 | OS | 73.8% |
| Zhou et al. [23] 2016 | China | AB209630 | NSCLC | down-regulation | qRT-PCR | 103/35 | fold change | 60 | OS | 73.8% |
| Xie et al. [15] 2014 | China | HMlincRNA717 | NSCLC | down-regulation | qRT-PCR | 49/69 | mean | 80 | OS | 78.6% |
| Nie et al. [24] 2016 | China | UCA1 | NSCLC | up-regulation | RT-PCR | 39/73 | Youden index | 80 | OS | 83.3% |
| Luo et al. [25] 2014 | China | CARLo-5 | NSCLC | up-regulation | qRT-PCR | 29/33 | median | 80 | OS | 73.8% |
| Zang et al. [26] 2016 | China | LINC01133 | NSCLC | up-regulation | qRT-PCR | 34/34 | fold change | 40 | OS/PFS | 73.8% |
| Nie et al. [17] 2014 | China | MVIH | NSCLC | up-regulation | qPCR | 21/21 | median | 40 | OS | 73.8% |
| Sun et al. [27] 2016 | China | NEAT1 | NSCLC | up-regulation | qRT-PCR | 67/29 | fold change | 40 | OS | 73.8% |
| Wang et al. [28] 2016 | China | PVT-1 | NSCLC | up-regulation | qRT-PCR | 74/71 | mean | 60 | OS | 78.6% |
| Zhao et al. [29] 2016 | China | SBF2-AS1 | NSCLC | up-regulation | qRT-PCR | 80/94 | median | 70 | OS | 83.3% |
| Zhang et al. [30] 2014 | China | TUG1 | NSCLC | down-regulation | qRT-PCR | 96/96 | median | 60 | OS | 73.8% |
| Wang et al. [31] 2015 | China | LINC01207 | NSCLC | up-regulation | qRT-PCR | 49/11 | fold change | 60 | OS | 78.6% |
| Deng et al. [32] 2015 | China | AFAP1-AS1 | NSCLC | up-regulation | qRT-PCR | 66/55 | NA | 60 | OS | 76.2% |
| Wang et al. [33] 2015 | China | UCA1 | NSCLC | up-regulation | qRT-PCR | 36/24 | median | 80 | OS | 83.3% |
| Zhang et al. [34] 2015 | China | LINC01133 | LSCC | up-regulation | qRT-PCR | NA | median | 60 | OS | 73.8% |
| Yang et al. [16] 2015 | China | ZXF2 | NSCLC | up-regulation | qRT-PCR | 27/13 | fold change | 36 | OS | 73.8% |
| Hou et al. [35] 2014 | China | Sox2ot | NSCLC | up-regulation | qRT-PCR | NA | fold change | 60 | OS | 83.3% |
| Han et al. [36] 2013 | China | GAS6-AS1 | NSCLC | down-regulation | qRT-PCR | 25/25 | mean | 60 | OS | 83.3% |
| Han et al. [37] 2015 | China | PANDAR | NSCLC | down-regulation | qRT-PCR | 70/70 | mean | 60 | OS | 83.3% |
| Li et al. [38] 2016 | China | AGAP2-AS1 | NSCLC | up-regulation | qPCR | 40/40 | mean | 40 | OS/PFS | 73.8% |
| Schmidt et al. [39] 2011 | Germany | MALAT1 | NSCLC | up-regulation | ISH | NA | NA | 56 | OS | 72.7% |
| Hiroshi et al. [40] 2014 | Japan | HOTAIR | SCLC | up-regulation | qRT-PCR | 8/10 | median | 125 | OS | 71.4% |
| Huang et al. [41] 2016 | China | PVT1 | SCLC | up-regulation | qRT-PCR | 60/60 | median | 96 | OS | 83.3% |
| Chen et al. [42] 2016 | China | CCAT2 | SCLC | up-regulation | qRT-PCR | 56/56 | median | 60 | OS | 83.3% |
| Liu et al. [43] 2016 | China | AK09398 | SCLC | up-regulation | qRT-PCR | 66/52 | median | 80 | OS/PFS | 73.8% |